CDT Equity Inc. (CDT) stock
CDTNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CDTTW
$0.36−0.02 (-4.51%)
Close on Nov 17, 2026Market cap $283.20KP/E –Yield –
CDT Equity operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
CDT Equity's operating income for the twelve months ending Jun 30, 2026 was -$34.85M. For fiscal 2025 it was -$36.76M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$36.76M | – |
| FY2024 | Dec 31, 2024 | -$15.42M | – |
| FY2023 | Dec 31, 2023 | -$5.26M | – |
| FY2022 | Dec 31, 2022 | -$3.16M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.00M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.66M | – |
| Q4 FY2025 | Dec 31, 2025 | -$21.16M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.03M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.95M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.62M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.51M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.81M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.14M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.96M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.43M | – |
| Q3 FY2023 | Sep 30, 2023 | -$430.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$888.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.52M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.67M | – |
| Q3 FY2022 | Sep 30, 2022 | -$933.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$279.42K | – |
| Q1 FY2022 | Mar 31, 2022 | -$263.72K | – |
See a number that looks wrong?